TITLE

Insulin: A Voice for Choice

AUTHOR(S)
Teuscher, Arthur
PUB. DATE
December 2007
SOURCE
Diabetes Health;Dec2007/Jan2008, Vol. 16 Issue 6, p18
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article discusses the dangers of hypoglycemic unawareness in diabetics who are taking human insulin. Human insulin came into use in the 1980s as a more physiological alternative to animal insulin, but some patients however reported a sudden loss of symptoms that had previously warned them that their blood sugar was low. This effect was subsequently confirmed in two clinical studies but nevertheless bovine and porcine insulin were withdrawn from the market. The author says there is not one insulin the fits all and alternatives should remain available.
ACCESSION #
28086695

 

Related Articles

  • CLINICAL CONSULTATION. Use of concentrated insulin human regular (U-500) for patients with diabetes. Segal, Alissa R.; Brunner, Jack E.; Burch, F. Taylor; Jackson, Jeffrey A. // American Journal of Health-System Pharmacy;9/15/2010, Vol. 67 Issue 18, p1526 

    Purpose. The efficacy and safety of and key clinical considerations for using U-500 insulin human regular in the treatment of high-dose insulin-treated patients in a wide variety of settings are examined. Summary. U-500 regular insulin has been available in the United States since 1952, but only...

  • insulin aspart.  // Royal Society of Medicine: Medicines;2002, p305 

    The article presents information on insulin aspart, a recombinant biosynthetic human insulin analogue, which is used in diabetic treatment to maintain diabetic patients. Insulin aspart has a faster rate of onset and offset of action than soluble insulin. Administration is by injection.

  • insulin lispro.  // Royal Society of Medicine: Medicines;2002, p305 

    The article presents information on insulin lispro, a recombinant biosynthetic human insulin analogue, which is used in diabetic treatment to maintain diabetic patients. Insulin lispro is relatively short-acting. Administration is by injection.

  • A Case of Suppurative Granuloma Induced by Insulin Injection. Tanizaki, Hideaki; Matsumura, Vumi; Tokura, Yoshiki; Miyachi, Yoshiki; Kabashim, Kenji // Acta Dermato-Venereologica;2010, Vol. 90 Issue 5, p540 

    The article presents a case study of a 76-year-old woman with diabetes mellitus presenting with multiple deep-seated, slightly pruritic, symmetrical skin nodules on the flanks and thighs. She claimed that the lesion appeared two-three days after insulin injections. A skin biopsy of an...

  • Insulin glargine overdose. Doğan, Fatma Sarı; Onur, Özge Ecmel; Altınok, Arzu Denizbaşı; Güneysel, Özlem // Journal of Pharmacology & Pharmacotherapeutics;Oct-Dec2012, Vol. 3 Issue 4, p333 

    Insulin glargine is a long acting novel recombinant human insulin analogue indicated to improve glycemic control, in adults and children with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus. The time course of action of insulins including insulin glargine may vary between...

  • YOUR DRUG WAS DISCONTINUED. Weil, Andrew // Time International (South Pacific Edition);5/8/2006, Issue 18, p139 

    The article presents information on issues related to the substitution of animal insulin with the synthetic one. The selling of animal insulin has been terminated in the U.S. from April 1, 2006, and synthetic human insulin, produced by recombinant-DNA technology, have entered the markets....

  • Insulin-producing neurospheres.  // PLoS Medicine;Apr2005, Vol. 2 Issue 4, p269 

    Discusses research being done on the differentiation of insulin-producing cells from human neural progenitor cells. Reference to a study by Seung Kim and colleagues published in this issue; Availability of recombinant insulin; Search for renewable sources of insulin-producing cells through...

  • Insulin Utopia. Trecroci, Daniel // Diabetes Health;Dec2008/Jan2009, Vol. 17 Issue 6, p7 

    The article discusses the available insulins for every diabetes type. New insulins include a 24-hour insulin called Lantus which was approved in 2001, Levemir approved in 2005, fast-acting insulin called Apidra which was approved in 2004, Humalog, and NovoLog. These insulins were formulated to...

  • An alternative insulin for diabetic dogs. Blake, Avi // Veterinary Medicine;Oct2012, Vol. 107 Issue 10, p430 

    The article discusses alternative insulin for dogs with diabetes mellitus in the U.S. It mentions that some of them suffering from the said disease are insufficiently controlled with neutral protamine Hagedorn (NPH) insulin which led veterinarians to search for a longer-acting insulin...

Share

Read the Article

Courtesy of

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics